Aba Chemicals Corporation(300261)
Prior approval opinions of independent directors on relevant matters
Aba Chemicals Corporation(300261) (hereinafter referred to as "the company") plans to hold the 25th meeting of the Fourth Board of directors on February 10, 2022. As an independent director of the company, I have carefully reviewed the materials related to the second and fifteenth meetings of the Fourth Board of directors in accordance with the Listing Rules of Shenzhen Stock Exchange on the gem, the guidelines for the standardized operation of companies listed on the gem of Shenzhen Stock Exchange and other relevant laws and regulations as well as the provisions of the articles of association. I hereby express my prior approval opinions on the relevant matters as follows:
1、 Proposal on the prediction of daily connected transactions in 2022
According to the Shenzhen Stock Exchange GEM Listing Rules and the articles of association and other relevant provisions, we have made a pre deliberation on the expected situation of the company's daily connected transactions. We believe that the company, its subsidiaries and Xiangyang Yuchang Fine Chemical Co., Ltd The amount of daily related party transactions and product processing service fees between Fuxin fulongbao Pharmaceutical Technology Co., Ltd. in 2022 shall be reasonably predicted. The transaction pricing shall refer to the market principle and determined by both parties through friendly negotiation. There is no situation that damages the interests of shareholders, especially small and medium-sized investors and the company. Therefore, it is agreed to submit the above matters to the 25th meeting of the Fourth Board of directors for deliberation.
(there is no text on this page, which is the signature page of Aba Chemicals Corporation(300261) independent directors' prior approval opinions on relevant matters)
Li Yuanxu, ye Jianfang, Xu Dan
specific date
